Trial
NCT00871533
Pilot Study of IFN α2b for Melanoma Patients
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pittsburgh
Collaborators
Schering-Plough
Condition
Melanoma
Intervention
IFNα2b
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-04